Reducing Cardiovascular Risk With Effective Management Of LDL Cholesterol - A Roundtable Discussion

Please note: This course is not available to residents of the US.​​​​​​

Overview

This roundtable is designed to provide clinicians with a better understanding of the long-term CV risks of LDL-C exposure. In addition to reviewing the pathogenesis of atherosclerosis and assessing the long-term implications of elevated LDL-C, this meeting will consider current guidance around controlling LDL-C, the challenges in achieving LDL-C targets, and evaluating how emerging strategies are contributing to LDL-C management. 

Each chapter will comprise of a short presentation by the named medical expert followed by a panel discussion amongst all faculty.  

Target Audience

This programme is intended to educate:

  • Healthcare professionals 
  • General cardiologists

This course is not available to residents of the US.

Learning Objectives

  • Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
  • Describe the clinical challenges in achieving guidance-based LDL-C goals
  • Compare and contrast LDL-C lowering therapies 
     

Disclosures

This medical experts round table discussion was organised independently by Radcliffe Cardiology, work that was funded by Novartis. It is intended for healthcare professionals as medical educational material, and may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities.
 

R-CME Disclaimer / Terms & Conditions

Radcliffe Education requires contributors to our IME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

This medical experts roundtable discussion was organised independently by Radcliffe Cardiology and has been funded by Novartis. It is intended for healthcare professional as medical educational material and may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. 

Course summary
Course opens: 
11/04/2020
Course expires: 
07/31/2024
Cost:
£0.00
Rating: 
0
  1. Welcome and Introductions – All
  2. The role of long-term exposure to elevated LDL-C in the pathogenesis of atherosclerosis and clinical risk - Lale Tokgözoglu
  3. Current approaches to controlling LDL-C: what do the guidelines say? - Christie Ballantyne
  4. Challenges in achieving guideline-based LDL-C targets in the real world - Kausik (Kosh) Ray
  5. Contemporary approaches to managing LDL-C and CV risk - Wolfgang Koenig
  6. Summary - All 

Dr Christie Ballantyne Baylor College of Medicine, Houston, TX, US

Prof Wolfgang Koenig  Technical University of Munich, Munich, DE

Prof Kausik (Kosh) Ray Imperial College London, London, UK

Dr Lale Tokgözoglu Haceteppe University, Ankara, Turkey

 

 

 

 

This content is not accredited for CME.

Price

Cost:
£0.00
Please login or register to take this course.